BlackRock Investment Management’s NEPHROGENEX INC COM NRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-813
Closed 4234
2016
Q1
$0 Hold
813
﹤0.01% 4137
2015
Q4
$1K Hold
813
﹤0.01% 4085
2015
Q3
$3K Buy
813
+142
+21% +$623 ﹤0.01% 4058
2015
Q2
$4K Buy
671
+103
+18% +$783 ﹤0.01% 4017
2015
Q1
$4K Hold
568
﹤0.01% 3920
2014
Q4
$8K Hold
568
﹤0.01% 3777
2014
Q3
$3K Hold
568
﹤0.01% 3991
2014
Q2
$3K Buy
+568
New +$3.62K ﹤0.01% 3979

BlackRock Investment Management's NRX Position: Q2 2016 in Review

BlackRock Investment Management sold out of NEPHROGENEX INC COM (NRX) in Q2 2016, closing a stake of 813 shares.

BlackRock Investment Management first reported a position in NRX in Q2 2014 and held it in 8 quarters. The position peaked at $8K in Q4 2014. 1 fund tracked by Wall St. Rank holds NRX as of Q2 2016.

  • BlackRock Investment Management reported no remaining NEPHROGENEX INC COM position as of Q2 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 813 NEPHROGENEX INC COM shares in Q2 2016.
  • BlackRock Investment Management first reported a position in NEPHROGENEX INC COM in Q2 2014 and held it in 8 quarters.
  • BlackRock Investment Management's NEPHROGENEX INC COM position peaked at $8K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.